Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure

Upon myocardial damage, the release of cardiac proteins induces a strong antibody-mediated immune response, which can lead to adverse cardiac remodeling and eventually heart failure (HF). Stem cell therapy using mesenchymal stromal cells (MSCs) or cardiomyocyte progenitor cells (CPCs) previously sho...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Hoogen, Patricia, de Jager, Saskia C. A., Mol, Emma A., Schoneveld, Arjan S., Huibers, Manon M. H., Vink, Aryan, Doevendans, Pieter A., Laman, Jon D., Sluijter, Joost P. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938331/
https://www.ncbi.nlm.nih.gov/pubmed/31891633
http://dx.doi.org/10.1371/journal.pone.0227283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938331/
https://www.ncbi.nlm.nih.gov/pubmed/31891633
http://dx.doi.org/10.1371/journal.pone.0227283

Ejemplares similares